指南与共识技术与安全MR

放射治疗中MRI的B0场均匀性推荐、规格与测量单位

B0 field homogeneity recommendations, specifications, and measurement units for MRI in radiation therapy.
指南 / 共识 · Med Phys · 2020-07-19

该指南基于文献提出放疗MRI空间完整性、图像模糊、脂肪饱和与零带的质量推荐,评估34台商用全身MRI的B0均匀性规格,并在6台MRI系统上测量B0场均匀性。结果显示40 cm DSV下1.5 T系统VRMS规格0.35–5 ppm(中位0.75 ppm),3 T系统0.2–1.4 ppm(中位0.5 ppm),可用DSV为16–49 cm(中位35 cm),VRMS与SD测量高度相关。

要点

  • 放疗MRI需最小化图像模糊和伪影(零带、信号去相位),同时优化空间完整性和脂肪饱和。
  • 40 cm DSV下1.5 T系统B0均匀性VRMS规格0.35–5 ppm(中位0.75 ppm),3 T系统0.2–1.4 ppm(中位0.5 ppm)。
  • 基于图像质量推荐和厂商规格,可用DSV为16–49 cm(中位35 cm)。

核心结论

  • 从危及器官中勾画病变是放疗的主要优先事项,因此放疗的场均匀性性能必须最小化图像模糊和图像伪影(零带和信号去相位),同时优化空间完整性和脂肪饱和。
  • 基于场均匀性的规格和推荐,一些MRI系统不太适合满足放疗的严格要求,尤其是体部MRI所用的大成像体积。
  • 在放疗应用中,B0场均匀性的VRMS和SD测量往往比pk-pk和FWHM更稳定且对场不均匀性更敏感。

研究设计与样本

  • 该文件为放疗MRI的B0场均匀性推荐、规格与测量单位指南,基于文献制定空间完整性、图像模糊、脂肪饱和和零带的质量推荐。
  • 评估了GE、Philips、Siemens和Canon提供的34台商用全身MRI系统在不同直径球体积(DSV)下的保证(最大)和典型B0场均匀性规格。
  • 在6台MRI系统上测量B0场均匀性,包括Philips(1.5 T)、Siemens(1.5和3 T)和ViewRay MRI(0.35 T)系统,使用24和35 cm DSV球形模体。
  • 测量技术包括:MRI相位对比场映射测量峰峰值(pk-pk)、体积均方根(VRMS)和标准差(SD);MR波谱采集体积自由感应衰减(FID)测量半高全宽(FWHM)。
  • 测量在有和无梯度匀场(gradshim)或二阶主动匀场下进行,并进行多重比较、方差分析(ANOVA)和Pearson相关性分析。

关键影像表现/征象

  • 在40 cm DSV下,1.5 T系统B0均匀性VRMS规格范围为0.35至5 ppm(中位0.75 ppm),3 T系统为0.2至1.4 ppm(中位0.5 ppm)。
  • 基于图像质量推荐和厂商规格,可用DSV范围为16至49 cm(中位35 cm)。
  • 六台测量的场均匀性与厂商规格总体符合,但在两台系统中观察到<35 cm DSV的信号去相位。
  • pk-pk、VRMS、SD和FWHM之间的关系因MRI系统、匀场体积和匀场质量而异,但VRMS和SD测量高度相关。

诊断标准与关键数值

  • 放疗MRI质量推荐涵盖空间完整性、图像模糊、脂肪饱和和零带,基于文献制定。
  • B0场均匀性规格以不同DSV下的保证(最大)和典型VRMS值表示,1.5 T系统40 cm DSV下为0.35–5 ppm(中位0.75 ppm),3 T系统为0.2–1.4 ppm(中位0.5 ppm)。
  • 测量指标包括pk-pk、VRMS、SD(相位对比场映射)和FWHM(MR波谱)。

临床应用与阅片要点

  • 放疗MRI的场均匀性评估应关注图像模糊、零带和信号去相位等伪影,以及空间完整性和脂肪饱和。
  • 在放疗应用中,VRMS和SD测量比pk-pk和FWHM更稳定且对场不均匀性更敏感。
  • 基于厂商规格和图像质量推荐,可估计各系统适用的DSV,部分系统不太适合放疗的大成像体积需求。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The purpose is: (a) Relate magnetic resonance imaging (MRI) quality recommendations for radiation therapy (RT) to B0 field homogeneity; (b) Evaluate manufacturer specifications of B0 homogeneity for 34 commercial whole-body MRI systems based on the MRI quality recommendations and RT application; (c) Measure field homogeneity in five commercial MRI systems and one commercial MRI-Linac used in RT and compare the results with their B0 homogeneity specifications.

METHODS: Magnetic resonance imaging quality recommendations for spatial integrity, image blurring, fat saturation, and null banding in RT were developed based on the literature. Guaranteed (maximum) and typical B0 field homogeneity specifications for various diameter spherical volumes (DSVs) were provided by GE, Philips, Siemens, and Canon. For each system, the DSV that conforms to each MRI quality recommendation and anatomical RT application was estimated based on the manufacturer specifications. B0 field homogeneity was measured on six MRI systems including Philips (1.5 T), Siemens (1.5 and 3 T), and ViewRay MRI (0.35 T) systems using 24 and 35 cm DSV spherical phantoms. Two measurement techniques were used: (a) MRI using phase contrast field mapping to measure peak-to-peak (pk-pk), volume root mean square (VRMS), and standard deviation (SD); and (b) Magnetic resonance (MR) spectroscopy by acquiring a volumetric free induction decay (FID) to measure full width at half maximum (FWHM). The measurements were used to assess: (a) conformance with the manufacturer specifications; and (b) the relationship between the various field homogeneity measurement units. Measurements were made with and without gradient shimming (gradshim) or second-order active shimming. Multiple comparisons, analysis of variance (ANOVA), and Pearson correlations were performed to assess the dependence of pk-pk, VRMS, SD, and FWHM measurements of field homogeneity on shim volume, level of shim, and MRI system.

RESULTS: For a 40 cm DSV, the B0 homogeneity specifications ranged from 0.35 to 5 ppm (median = 0.75 ppm) VRMS for 1.5 T systems and 0.2 to 1.4 ppm (median = 0.5 ppm) VRMS for 3 T systems. The usable DSVs ranged from 16 to 49 cm (median = 35 cm) based on the image quality recommendations and the manufacturer specifications. There was general compliance between the six measured field homogeneities and manufacturer specifications although signal dephasing was observed in two systems at < 35 cm DSV. The relationships between pk-pk, VRMS, SD, and FWHM varied based on MRI system, shim volume, and quality of shim. However, VRMS and SD measurements were highly correlated.

CONCLUSIONS: The delineation of the diseased lesion from organs at risk is the main priority for RT. Therefore, field homogeneity performance for RT must minimize image blurring and image artifacts (null bands and signal dephasing) while optimizing spatial integrity and fat saturation. Based on the specifications and recommendations for field homogeneity, some MRI systems are not well suited to meet the strict demands of RT particularly for the large imaging volumes used in body MRI. VRMS and SD measurements of B0 field homogeneity tend to be more stable and sensitive to field inhomogeneities in RT applications than pk-pk and FWHM.

来源:Med Phys,查看原文。版权归原作者所有。

引用

  1. Gach HM, Curcuru AN, Mutic S, et al. B0 field homogeneity recommendations, specifications, and measurement units for MRI in radiation therapy. Med Phys. 2020. PMID: 32472707. doi:10.1002/mp.14306

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。